microarray, methylation analysis of imprinting centres on 11p15.5 and CDKN1C (P57) mutation screening. Rare point mutations in NSD1, NLRP2, DNMT1 and ZFP57 have been described in BWS and like disorders
Total twenty four kinds of mutation, which 18 point mutation, 4 insertion & 2 deletion were observed in 81-bp RRDR region of rpoB gene. Conclusion: The sequencing analysis for genotypic
mutations in the PRNP gene. There are two major types of mutations in PRNP : point mutations leading to amino acid substitutions and mutations leading to expansions of the octapeptide repeat
Ulcer, 1 patient with esophagitis and 5 normal patients. Allele-specific PCR detect A2142G point mutation in 9/97 (9.3%). The DNA sequencing of 25 specimens confirms the presence ... above mutation in addition to 3…
G.ulcer, 1 patient with esophagitis and 5 normal patients. Allele-specific PCR detect A2142G point mutation in 9/97 (9.3%). The DNA sequencing of 25 specimens confirms the presence ... above mutation in addition to 3…
sequencing of G6PC1 exons revealed the missense mutation in exon 5; a substitutive point mutation at 992nd base position of exon 5, showing substitution of T in the place
rCRS using the DNAstar program. The result of mutation analysis shows the presence of point mutation in some mtG region fragments with different mutation proportions. Most mutations outside the HVS1
addition to that, analysis of somatic mutation gives us that CFH has the highest point mutation 9,92%. Conclusion: Overall, the MLL genomic characterization shows that it is different than
particular RNA viruses—have relatively high mutation rates (on the order of one point mutation or more per genome per round of replication). This elevated mutation rate, when combined with
particular RNA viruses—have relatively high mutation rates (on the order of one point mutation or more per genome per round of replication). This elevated mutation rate, when combined with
world. The resistance has been attributed to mutations in lipid A biosynthesis genes and point mutation in PmrAB-two component response regulator and sensor kinase system. The emergence of plasmid
groups (f1-1 and f1-2). One of the groups possessed one-nucleotide mutation point with one amino-acid substitution. The mutated Asp f 2 gene accompanying 6-amino acid
subcloning confirmed a deletion- or insertion-type mutation. Fourteen single-band samples carried a point mutation that presented single base-pair double peaks on direct sequencing. Six single-band samples
leukemia (AML) involves the cooperation of mutations promoting proliferation/ survival and those impairing differentiation. point mutations of the N-RAS gene are the most frequent somatic mutations causing aberrant…
Background: Point mutations within ABL kinase domain (AKD) of the BCR-ABL gene are the most common cause of resistance to Imatinib Mesylate (IM) treated Chronic Myeloid Leukemia (CML) patients
tandem duplication (ITD) mutations within the juxtamembrane domain of FLT-3 gene and missense point mutations in the tyrosine kinase domai. Several studies have demonstrated a poor overall survival with
main target of somatic mutations in acute B lymphoblastic leukemia (B-ALL). For example, point mutations, deletions, as well as other gene rearrangements may lead to several forms
indeed NR-deficient. Mutation analysis of NR cDNA sequences revealed that there were 11 point mutations shared by the J-1, J-2, and J-3 mutants. Furthermore, the results
EGFR gene mutations, are in-frame deletions in exon 19 (LREA deletions) and point mutations in exon 21 (L858R). Exon 18 mutations occur much less frequently at about
Also the mutation N145S was presented in the receptorbinding site of all segments analyzed. Point mutations in several positions in the gene encoding the H3 of Tunisian strains were shown
secondary mutations in ALK are responsible for crizotinib resistance in patients. C1156Y is a point mutation seen in patients resistant to crizotinib. Although second and third-generation ALK inhibitors
Mutations of PLCG2 promote B cell receptor signaling despite BTK inhibition. Recently, several BTK point mutations causing acquired resistance to non-covalent BTKi have been reported, including T474I, L528W, A428D
For authors and organisers
Publish, present and keep up with your field
Find the right journal for your paper and submit your manuscript.